Recent developments in bisphosphonates for patients with metastatic breast cancerGAINFORD, Mary C; DRANITSARIS, George; CLEMONS, Mark et al.BMJ. British medical journal (International ed.). 2005, Vol 330, Num 7494, pp 769-773, issn 0959-8146, 5 p.Article

A randomized trial to measure the optimal role of the pharmacist in promoting evidence-based antibiotic use in acute care hospitalsDRANITSARIS, George; SPIZZIRRI, Diana; PITRE, Monique et al.International journal of technology assessment in health care. 2001, Vol 17, Num 2, pp 171-180, issn 0266-4623Article

Implementing evidence based antiemetic guidelines in the oncology setting : results of a 4-month prospective intervention studyDRANITSARIS, George; LEUNG, Pauline; WARR, David et al.Supportive care in cancer. 2001, Vol 9, Num 8, pp 611-618, issn 0941-4355Article

Measuring treatment preferences and willingness to pay for docetaxel in advanced ovarian cancerDRANITSARIS, George; ELIA-PACITTI, Julia; COTTRELL, Wayne et al.PharmacoEconomics (Auckland). 2004, Vol 22, Num 6, pp 375-387, issn 1170-7690, 13 p.Article

Small molecule targeted therapies for the second-line treatment for metastatic renal cell carcinoma: a systematic review and indirect comparison of safety and efficacyDRANITSARIS, George; SCHMITZ, Susanne; BROOM, Reuben J et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 11, pp 1917-1926, issn 0171-5216, 10 p.Article

The development of a value based pricing index for new drugs in metastatic colorectal cancerDRANITSARIS, George; TRUTER, Ilse; LUBBE, Martie S et al.European journal of cancer (1990). 2011, Vol 47, Num 9, pp 1299-1304, issn 0959-8049, 6 p.Article

nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trialDRANITSARIS, George; COLEMAN, Robert; GRADISHAR, William et al.Breast cancer research and treatment. 2010, Vol 119, Num 3, pp 717-724, issn 0167-6806, 8 p.Article

The autologous blood and marrow transplant long-term follow-up clinic: a model of care for following and treating survivors of autotransplantSCHIMMER, Aaron D; DRANITSARIS, George; ALI, Val et al.Supportive care in cancer. 2002, Vol 10, Num 3, pp 247-252, issn 0941-4355Article

Switching Breast Cancer Patients with Progressive Bone Metastases to Third-Generation Bisphosphonates: Measuring Impact Using the Functional Assessment of Cancer Therapy-Bone PainBROOM, Reuben; HONGYAN DU; CLEMONS, Mark et al.Journal of pain and symptom management. 2009, Vol 38, Num 2, pp 244-257, issn 0885-3924, 14 p.Article

The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclinesDRANITSARIS, George; RAYSON, Daniel; VINCENT, Mark et al.Breast cancer research and treatment. 2008, Vol 107, Num 3, pp 443-450, issn 0167-6806, 8 p.Article

Sterile versus nonsterile gloves for repair of uncomplicated lacerations in the emergency department: A randomized controlled trialPERELMAN, Vsevolod S; FRANCIS, Gregory J; RUTLEDGE, Tim et al.Annals of emergency medicine. 2004, Vol 43, Num 3, pp 362-370, issn 0196-0644, 9 p.Article

Randomized Feasibility Study of De-escalated (Every 12 wk) Versus Standard (Every 3 to 4 wk) Intravenous Pamidronate in Women With Low-risk Bone Metastases From Breast CancerAMIR, Eitan; FREEDMAN, Orit; CARLSSON, Lindsay et al.American journal of clinical oncology. 2013, Vol 36, Num 5, pp 436-442, issn 0277-3732, 7 p.Article

A Phase 2 Trial Exploring the Effects of High-Dose (10,000 IU/Day) Vitamin D₃ in Breast Cancer Patients With Bone MetastasesAMIR, Eitan; SIMMONS, Christine E; FREEDMAN, Orit C et al.Cancer. 2010, Vol 116, Num 2, pp 284-291, issn 0008-543X, 8 p.Article

Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast CancerAMIR, Eitan; MILLER, Naomi; TANNOCK, Ian F et al.Journal of clinical oncology. 2012, Vol 30, Num 6, pp 587-592, issn 0732-183X, 6 p.Article

Altered Calcium Metabolism in Patients on Long-term Bisphosphonate Therapy for Metastatic Breast CancerSIMMONS, Christine; AMIR, Eitan; DRANITSARIS, George et al.Anticancer research. 2009, Vol 29, Num 7, pp 2707-2711, issn 0250-7005, 5 p.Article

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patientsFREEDMAN, Orit; AMIR, Eitan; AHMAD, Imran et al.Breast cancer research and treatment. 2009, Vol 118, Num 2, pp 377-383, issn 0167-6806, 7 p.Article

Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and deathRAKOVITCH, Eileen; PIGNOL, Jean-Philippe; CHARTIER, Carole et al.Breast cancer research and treatment. 2005, Vol 90, Num 2, pp 139-148, issn 0167-6806, 10 p.Article